Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
4 minute read
  • Biotech
  • FDA
  • General
  • Guidance
  • IPOs
  • News
  • Penny Stocks
  • Small Cap

The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts

By Shanthi Rexaline
Today, 7:41 AM
Here's a roundup of top developments in the biotech space over the last 24 hours:

CBIO

Read More
4 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

50 Biggest Movers From Yesterday

By Lisa Levin
Today, 7:41 AM
Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target.

ADGI

Read More
1 minute read
  • ETFs
  • Long Ideas
  • News
  • Sector ETFs
  • Small Cap
  • Tech
  • Trading Ideas

Cathie Wood Buys Another $800K In This Elon Musk-Led SpaceX’s 3D Printing Partner

By Rachit Vats
Today, 7:41 AM
Cathie Wood-led Ark Investment Management on Wednesday bought 102,790 shares, estimated to be worth about $814,097, in Velo3D Inc (NYSE: VLD), the 3D company that went public earlier this month via a merger with special purpose acquisition company Jaws Spitfire Ac

ARKQ

Read More
3 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

39 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin
Today, 7:41 AM
Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares jumped 113% to $15.36 after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target.

CRSP

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Stifel Maintains Hold on CRISPR Therapeutics, Lowers Price Target to $101

By Benzinga Newsdesk
Today, 7:41 AM
Stifel analyst Benjamin Burnett maintains CRISPR Therapeutics (NASDAQ:CRSP) with a Hold and lowers the price target from $139 to $101.

CRSP

Read More
1 minute read
  • General
  • Hedge Funds
  • Trading Ideas

Cathie Wood’s ARK Invest Posts Fund Purchases For Tuesday, Oct. 12 2021: TDOC, CRSP, NTLA, SSYS, MKFG, BLDE, VLD, GENI, TWOU, CDNA, ARCT, SLGC, BEAM, QSI, DYNS

By Michael Horton
Today, 7:41 AM
Teladoc Health (TDOC) - 198,681 Shares CRISPR Therapeutics (CRSP) - 61,732 Intellia Therapeutics (NTLA) - 13,254 Stratasys (SSYS) - 26,989 Markforged (MKFG) - 179,691 Blade Air Mobility (BLDE) - 94,782 Velo3D

ARCT

Read More
4 minute read
  • Biotech
  • Earnings
  • FDA
  • General
  • News
  • Offerings
  • Penny Stocks
  • Small Cap

The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal

By Shanthi Rexaline
Today, 7:41 AM
Here's a roundup of top developments in the biotech space over the last 24 hours.

ATRA

Read More
2 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

20 Stocks Moving in Wednesday’s Pre-Market Session

By Lisa Levin
Today, 7:41 AM
Gainers Puxin Limited (NYSE: NEW) rose 52.1% to $0.6901 in pre-market trading after dipping 24% on Tuesday.

APEN

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • FDA
  • General
  • News

‘I spoke to $CRSP CEO Sam Kulkarni and @UrnovFyodor about the $ALLO “chromosomal abnormality”safety issue. Kulkarni said he thinks CTX110 won’t be affected.’ -Tweet From STAT News’ Adam Feuerstein

By Benzinga Newsdesk
Today, 7:41 AM
https://www.twitter.com/i/status/1448017211709394947

CRSP

Read More
1 minute read
  • FDA
  • Movers
  • News
  • Trading Ideas

CRISPR Therapeutics Shares Move Lower; STAT News Reporter Tweets ‘New data on $CRSP off-the-shelf CAR-T cancer therapy shows more remissions, no major safety issues’

By Benzinga Newsdesk
Today, 7:41 AM
https://www.statnews.com/2021/10/12/crispr-therapeutics-car-t-therapy-update/

CRSP

Posts navigation

Previous 1 … 7 8 9 … 12 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service